Michael Raphael Tadross

Our goal is to bridge the gap between the study of brain as a computational device and the search for novel neuropathological treatments. We develop technologies to manipulate molecules, cells, and synapses in the brain, and deploy these reagents in mouse models of disease.

Selected Grants

The role of dystrophin in synapse development.

ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2024 - 2029

Neurobiology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

DART.3-Revolutionizing Neuropsychiatric Treatment through Noninvasive, Programmable Cell-Type-Specific Neuropharmacology

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2027

University Training Program in Biomolecular and Tissue Engineering

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1994 - 2027

Unmasking neuromodulatory control of locomotion

ResearchPrincipal Investigator · Awarded by Washington University in St. Louis · 2024 - 2027

CIRCUIT MECHANISMS FOR DOPAMINE NEURON VULNERABILITY AND RESILIENCE IN PD - Extension

ResearchCo Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2021 - 2026

Neuroactive steroids as novel psychiatric treatments: mechanistic studies

ResearchPrincipal Investigator · Awarded by Washington University in St. Louis · 2021 - 2026

High-resolution measurement of natural stimuli and ethologically relevant behavior as platform for understanding the nervous system

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2024 - 2026

Parvalbumin interneurons regulate nucleus accumbens synapses and behavior

ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2021 - 2025

Cerebellar pathology in the absence of plasticity gating

ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2021 - 2025

Interrogating the cholinergic basis of opioid reinforcement with subcellular precision

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2025

GRIP Display NCBioTech

ResearchPrincipal Investigator · Awarded by North Carolina Biotechnology Center · 2023 - 2025

Combating obesity via cell-specific pharmacology of dopamine neurons

FellowshipPrincipal Investigator · Awarded by American Heart Association · 2023 - 2024

Evaluating cell type-specific non-dopaminergics as a Parkinson's treatment paradigm

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2024

Striatal Microcircuit Drivers of Adaptive Learning in Habit Formation

ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2023

Interrogating dynamics of whole-brain volumes with cell type-specific pharmacology

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2023

Receptive field coordination across mosaics of diverse retinal ganglion cell types in the mammalian retina

ResearchCollaborator · Awarded by National Institutes of Health · 2020 - 2022

DART2.0: comprehensive cell type-specific behavioral neuropharmacology

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2022

Significance of excitatory and inhibitory synaptic integration by interneurons for local circuit dynamics and behavior

FellowshipCo-Sponsor · Awarded by National Institutes of Health · 2020 - 2021

Deconstructing the Behavioral Neuropharmacology of Parkinson's Disease

ResearchPrincipal Investigator · Awarded by Parkinson's Disease Foundation · 2017 - 2020

Interrogating brain dynamics with cell type-specific pharmacology

ResearchPrincipal Investigator · Awarded by Whitehall Foundation, Inc. · 2018 - 2019